Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2024-11-13 00:00:00 ET · period of report 2024-11-08 · accession 0001765581-24-000088 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-13 | 2024-11-08 | JAZZ | Patil Neena M | EVP, CLO | S - Sale | $123.41 | -3,700 | 33.0K | -10% | -$456.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2024-11-08 | S | D | 3,700 | $123.41 | 33,048 | D | — | — | (F1) Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $123.31 to $123.51. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. (F2) Includes 119 ordinary shares acquired on May 31, 2024 under a Section 423 Employee Stock Purchase Plan. |